Physician profile
Maher Ghanem
NPI 1922273515
$88,229.58
in general payments reported to CMS, 2019-2025
8 companies · $13K in 2025
The $13K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $22K · 2021: $21K · 2022: $4,326 · 2023: $5,551 · 2024: $4,405 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $20K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Food and Beverage: $1,263 · Travel and Lodging: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $20,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Food and Beverage | $1,262.90 |
| Travel and Lodging | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $87,924.41 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.00 | 2023 | Lifevest |
| Olympus America INC. | $67.13 | 2019 | |
| Medtronic, INC. | $61.24 | 2022-2023 | Ligasure |
| Smith+Nephew, INC. | $25.27 | 2023 | Stravix |
| Actelion Pharmaceuticals US, INC. | $18.09 | 2021 | |
| Integra Lifesciences Corporation | $17.76 | 2024 | Integra, Surgimend, Omnigraft |
| Alexion Pharmaceuticals, INC. | $15.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maher Ghanem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.